CLINICAL_TRIALS
trial_result
· 2025-03-11
Clinical Trial Update: REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE) [Phase 3]
Summary
A Phase 3 clinical trial (RESPONSE) is evaluating a reduced-dose steroid protocol for childhood nephrotic syndrome and is currently recruiting at multiple sites…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Hospital for Sick Children | Conditions: Nephrotic Syndrome in Children, Nephrotic Syndrome, Minimal Change | Phase 3 | Status: RECRUITING